about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF ...
Read More
9.96
-0.33
(-3.21%)
6.8M
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..